SDS: A Good Hedging Tool With A Caveat
https://seekingalpha.com/article/4791444-sds-good-hedging-tool-with-caveat?source=feed_tag_etf_portfolio_strategy
May 31, 2025 -
0
SHYD: Perfectly Adequate, Just Not Good Enough I Think
https://seekingalpha.com/article/4791329-shyd-perfectly-adequate-just-not-good-enough-i-think?source=feed_tag_etf_portfolio_strategy
May 30, 2025 -
0
JEQ: Probably Due A Pause, After A Good Run
https://seekingalpha.com/article/4790294-jeq-cef-probably-due-a-pause-after-a-good-run?source=feed_tag_etf_portfolio_strategy
May 27, 2025 -
0
Greggs: Trading Update Brought Good News
https://seekingalpha.com/article/4789961-greggs-trading-update-brought-good-news?source=feed_all_articles
May 26, 2025 -
0
KNOT Offshore Partners: Good Quarter But No Catalysts - Hold
https://seekingalpha.com/article/4789940-knot-offshore-partners-stock-q1-good-quarter-but-no-catalysts-reiterate-hold?source=feed_all_articles
May 26, 2025 -
0
TYG: A Good Risk/Reward Balance In The Energy Infrastructure Industry
https://seekingalpha.com/article/4789918-tyg-a-good-riskreward-balance-in-the-energy-infrastructure-industry?source=feed_tag_etf_portfolio_strategy
May 26, 2025 -
0
TOV: Good Idea, But Not Worth A Buy Due To High Fees
https://seekingalpha.com/article/4789764-tov-etf-good-idea-but-high-fees?source=feed_tag_etf_portfolio_strategy
May 25, 2025 -
0
Ambev Q1: Good Results Confirm The Recommendation
https://seekingalpha.com/article/4789756-ambev-q1-good-earnings-confirm-buy-recommendation?source=feed_all_articles
May 25, 2025 -
0
Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good
https://seekingalpha.com/article/4789023-dynavax-technologies-stock-hepatitis-b-vaccine-specialist-looking-good?source=feed_all_articles
May 21, 2025 -
0
DISV: Good ETF For International Small-Cap Value Exposure
https://seekingalpha.com/article/4788137-disv-good-etf-for-international-small-cap-value-exposure?source=feed_tag_etf_portfolio_strategy
May 19, 2025 -
0